Anti-areg/hb-egf antibodies and treatment

Details Anti-areg/hb-egf antibodies and treatment Anti-areg/hb-egf antibodies and treatment

C - Chemistry, Metallurgy

07

K

C07K 16/22 (2006.01) A61K 31/7088 (2006.01) A61K 39/395 (2006.01) A61P 35/00 (2006.01) G01N 33/577 (2006.01) C07K 14/485 (2006.01) C07K 16/28 (2006.01)

Patent

CA 2721032

Described are cross-specific antibody molecules with binding specificity for both AREG and HBEGF. The anti-body molecules may be used in methods of treatment of cancer and diseases associated with angiogenesis.

L'invention porte sur des molécules d'anticorps interspécifiques présentant une spécificité de liaison pour AREG et HBEGF. Les molécules d'anticorps peuvent être utilisées dans des procédés de traitement de cancers et de maladies associées à une angiogenèse.

Affiliated with

Also associated with

Rating

Anti-areg/hb-egf antibodies and treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-areg/hb-egf antibodies and treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-areg/hb-egf antibodies and treatment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1501940